戻る Agenda
Session 2 (Parallel Session) : Patient Diversity, Equity and Inclusion in Clinical Trials and Regulatory Insights
Session Chair(s)
Yunni Lim, RPH
Country Leader of Global Clinical Operations / President, KCDA
Roche Korea Co Ltd, Korea, Republic of
Hye Jong Yoo, RPH
Executive Director
AstraZeneca , Korea, Republic of
Speaker(s)
Vanessa Cahee
VCahee Consulting LLC, United States
Clinical Operations & Clinical Trial Diversity Consultant
Seonghae Yoon, MD, PHD
Seoul National University Bundang Hospital, Korea, Republic of
Monica Eason
Genentech, A Member of the Roche Group, United States
Clinical Operations Portfolio Leader
Pei-Chieh Fong
AstraZeneca Taiwan, Taiwan
Vice President, Medical International